Resmed (RMD) Receivables - Other (2018 - 2026)

Resmed (RMD) has 9 years of Receivables - Other data on file, last reported at $47.1 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 8.77% year-over-year to $47.1 million; the trailing twelve-month figure through Mar 2026 stood at $47.1 million (down 8.77% YoY), and the FY2025 full-year result was $51.2 million, up 34.03% from the prior year.
• Receivables - Other for Q1 2026 stood at $47.1 million, down from $61.4 million in the prior quarter.
• Across five years, Receivables - Other topped out at $61.4 million in Q4 2025 and bottomed at $23.1 million in Q4 2022.
• The 5-year median for Receivables - Other is $37.9 million (2024), against an average of $38.4 million.
• The widest annual swing landed in 2022, when Receivables - Other jumped 135.86%; it then declined 8.77% in 2026.
• A 5-year view of Receivables - Other shows it stood at $23.1 million in 2022, then surged by 49.62% to $34.6 million in 2023, then jumped by 35.98% to $47.0 million in 2024, then jumped by 30.61% to $61.4 million in 2025, then dropped by 23.29% to $47.1 million in 2026.
• The last three Receivables - Other figures came in at $47.1 million (Q1 2026), $61.4 million (Q4 2025), and $51.1 million (Q3 2025), per Business Quant data.

Peer Comparison